Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10561 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES ACQUISITION OF HEALTHBEACON PLC

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction at IMCAS World Congress 2024

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Sirnaomics, Inc.

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  NRx Pharmaceuticals, Inc.

Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Viatris Inc.

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Regen BioPharma, Inc.

IONETIX Announces Partnership with Provision Diagnostic Imaging with the launch of a new Cardiac PET/CT imaging program in Knoxville

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Ionetix Corporation

The American Diabetes Association Announces 2024 Pathway to Stop Diabetes Grant Recipients -- Spurring Innovation and Momentum in Diabetes Research

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  American Diabetes Association

Metro Vein Centers Launches in Texas With New State-of-the-Art Vein Clinics in the Houston Metroplex

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

HHS/SAMHSA Releases New Opioid Treatment Program (OTP) Regulations

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

Spyre Therapeutics Appoints Accomplished Biopharma and IBD Leader Mark C. McKenna, Former Chairman, President, and CEO of Prometheus Biosciences, to its Board of Directors

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Spyre Therapeutics, Inc.

Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Genprex, Inc.

Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Danaher Corporation

Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Palatin Technologies, Inc.

Onkos Surgical to Present at Canaccord Genuity's 2024 Musculoskeletal Conference

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Onkos Surgical

ProfoundBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of PRO1107, a Protein Tyrosine Kinase 7 (PTK7)-Targeted Antibody-Drug Conjugate Incorporating a Novel, Proprietary Hydrophilic MMAE-Based Linker-Drug

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  ProfoundBio

Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study in generalized myasthenia gravis (gMG) and a Phase 2 study in Sjögren's Disease (SjD)

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
Related companies:  Vanda Pharmaceuticals Inc.

Acarix CADScor System Now Listed on U.S. VA Federal Supply Schedule

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS PRIORITIZES WOMEN'S HEALTH WITH NEW CLINICAL TEAM AND EXPANDED CARE OPTIONS

Read more ››
By: PR Newswire Association LLC. - 05 Feb 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑